Works matching IS 13419625 AND DT 2024 AND VI 29 AND IP 8

Results: 19
    1
    2
    3

    Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1081, doi. 10.1007/s10147-024-02572-6
    By:
    • Hirose, Takeshi;
    • Ito, Mamoru;
    • Tsuchihashi, Kenji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro;
    • Nakao, Shinji
    Publication type:
    Article
    4

    Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1074, doi. 10.1007/s10147-024-02570-8
    By:
    • Nozawa, Kazuki;
    • Ozaki, Yukinori;
    • Yoshinami, Tetsuhiro;
    • Yokoe, Takamichi;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    5

    Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1067, doi. 10.1007/s10147-024-02569-1
    By:
    • Hirose, Takeshi;
    • Ito, Mamoru;
    • Tsuchihashi, Kenji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Kamiyama, Yutaro;
    • Nakao, Shinji
    Publication type:
    Article
    6
    7
    8

    New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1182, doi. 10.1007/s10147-024-02553-9
    By:
    • Fukushima, Ryosuke;
    • Harimoto, Norifumi;
    • Okuyama, Takayuki;
    • Seki, Takaomi;
    • Hoshino, Kouki;
    • Hagiwara, Kei;
    • Kawai, Shunsuke;
    • Ishii, Norihiro;
    • Tsukagoshi, Mariko;
    • Igarashi, Takamichi;
    • Araki, Kenichiro;
    • Tomonaga, Hiroyasu;
    • Higuchi, Tetsuya;
    • Shimokawa, Mototsugu;
    • Shirabe, Ken
    Publication type:
    Article
    9
    10

    Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1191, doi. 10.1007/s10147-024-02548-6
    By:
    • Hara, Shuhei;
    • Mori, Keiichiro;
    • Fukuokaya, Wataru;
    • Tomomasa, Naoya;
    • Oguchi, Takahiro;
    • Takahashi, Yusuke;
    • Saito, Shun;
    • Katami, Jun;
    • Sano, Takayuki;
    • Kadena, Soushi;
    • Hashimoto, Masaki;
    • Yata, Yuji;
    • Nishi, Eriko;
    • Suhara, Yushi;
    • Takamizawa, Shigeyoshi;
    • Kurawaki, Shiro;
    • Suzuki, Hirotaka;
    • Miyajima, Keiichiro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko
    Publication type:
    Article
    11

    The efficacy and safety of anamorelin among patients with diabetes.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1115, doi. 10.1007/s10147-024-02546-8
    By:
    • Ando, Kenju;
    • Naito, Tateaki;
    • Hamauchi, Satoshi;
    • Miura, Keita;
    • Nishibori, Yuichiro;
    • Tonsho, Ayumi;
    • Matsuda, Suguru;
    • Morita, Meiko;
    • Sekikawa, Motoki;
    • Doshita, Kosei;
    • Kodama, Hiroaki;
    • Yabe, Michitoshi;
    • Morikawa, Noboru;
    • Iida, Yuko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Ryo, Ko;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu
    Publication type:
    Article
    12
    13
    14

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    15

    Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1122, doi. 10.1007/s10147-024-02542-y
    By:
    • Yamakawa, Nobuhiro;
    • Okura, Masaya;
    • Hasegawa, Takumi;
    • Otsuru, Mitsunobu;
    • Sakai, Hironori;
    • Hirai, Eiji;
    • Rin, Shin;
    • Yamada, Shin-ichi;
    • Yanamoto, Souichi;
    • Yokota, Yusuke;
    • Umeda, Masahiro;
    • Kurita, Hiroshi;
    • Ueda, Michihiro;
    • Akashi, Masaya;
    • Kirita, Tadaaki
    Publication type:
    Article
    16
    17
    18
    19